Pembrolizumab

ATC L01FF02 · 11 markets · 46 records

Pembrolizumab 11 markets · 46 records Forms

GB 18 records · 16 strengths

Other strengths: 125 mg/50 mL injection、100 mg/50 mL injection、80 mg/50 mL injection、50 mg injection

AU 5 records · 5 strengths

  • 100 mg/4 mLinjectionKEYTRUDA also in GB·CN
  • 790 mg/mLinjectionKEYTRUDA SC pembrolizumab 395 mg/ 2.4 mL solution for injection vial unknown
  • 395 mg/mLinjectionKEYTRUDA SC pembrolizumab 395 mg/ 2.4 mL solution for injection vial unknown
  • 100 mginjectionKEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial unknown

Records without a stated strength · 1 KEYTRUDA

ES 4 records · 1 strengths

US 3 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 1 strengths

  • 25 mg/mLinjectionKEYTRUDA SOLUTION FOR INFUSION 25MG/MLPembrolizumab Solution for Infusion 25mg/mL

CN 2 records · 1 strengths

MX 1 records · 1 strengths

    Records without a stated strength · 1 KEYTRUDA SC

    TW 1 records · 1 strengths

      Records without a stated strength · 1 KEYTRUDA、吉舒達注射劑

      HK 1 records · 1 strengths

        Records without a stated strength · 1 KEYTRUDA SOLUTION FOR INJECTION 100MG/4ML

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          Records without a stated strength · 1 KEYTRUDA

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

          A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.